Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Methylprednisolone in COVID-19 with high oxygen flow
NCT05062681Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in coronavirus disease 2019 (COVID-19), sponsored by Cairo University. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05062681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05062681.